Auron will present data highlighting the activity of AUTX-703, its oral, potent and selective degrader targeting KAT2A/B in cell lines and patient derived organoid models (PDXO) of neuroendocrine ...

YONGIN, South Korea, March 20, 2025 /PRNewswire/ -- Noul Co., Ltd. a Korea-based medical AI company, announced that it presented a poster titled "Bridging Medical Gaps from Malaria to Cancer ...